DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Ibudilast
Ibudilast
Chapter Introduction
Annual Report 2016
Effect of Ibudilast: a Novel Antiasthmatic Agent, on Airway Hypersensitivity in Bronchial Asthma
Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1
(12) United States Patent (10) Patent No.: US 9.254.262 B2 Casado Et Al
1 Elevated Intracellular Camp Concentration Mediates Growth
Ibudilast for Alcohol Use Disorder: Study Protocol for a Phase II Randomized Clinical Trial Elizabeth M
(12) Patent Application Publication (10) Pub. No.: US 2003/0068365A1 Suvanprakorn Et Al
Stembook 2018.Pdf
Aminophylline Suppresses Stress-Induced Visceral Hypersensitivity and Defecation in Irritable Bowel Syndrome
Elevated Intracellular Camp Concentration Mediates Growth Suppression in Glioma Cells
Ibudilast : a Review of Its Pharmacology, Efficacy and Safety in Respiratory and Neurological Disease
COPD Presented by America’S Biopharmaceutical Research Companies
Inhibition of PAF-Induced Eosinophil Accumulation in Pulmonary Airways of Guinea Pigs by Anti-Asthma Drugs Shahin SANJAR, Sakai
(12) Patent Application Publication (10) Pub. No.: US 2005/0165041 A1 Hanauer Et Al
Section B Changed Classes/Guidelines Final Version Date of Issue
Phosphodiesterase Inhibitors Applied Via the Transvaginal Route for the Treatment of Infertility
2010-Poster Tms
Top View
Treatment for Bronchial Asthma— Kazuo AKIYAMA
(12) Patent Application Publication (10) Pub. No.: US 2013/0252924 A1 Penninger Et Al
Marrakesh Agreement Establishing the World Trade Organization
III SEQT Summer School MEDICINAL CHEMISTRY in DRUG DISCOVERY the PHARMA PERSPECTIVE
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
)&F1y3x PHARMACEUTICAL APPENDIX to THE
ROFLEX™: a NOVEL FORMULATION for TREATMENT of RESPIRATORY and ANXIETY DISORDERS Pondera Biotechnologies, Inc. CLINICAL NEEDS
2012 GINA Report, Global Strategy for Asthma Management and Prevention
NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
Section a Changed Classes/Guidelines
Customs Tariff - Schedule Xxi - 1
(12) United States Patent (10) Patent N0.: US 8,580,801 B2 Henkin (45) Date of Patent: Nov
Phosphodiesterase-4 Inhibitors for Non-COPD Respiratory Diseases
Calpain Inhibitor and Ibudilast Rescue Β Cell Functions in a Cellular Model of Wolfram Syndrome
A Quantitative Structure – Toxicity Relationship of Drugs on Rat Summary
Methods Coronavirus Disease 2019 (COVID-19)
Literature Search Strategy for Treatment of Stable
A Small Molecule Drug Screening Identifies Colistin Sulfate As an Enhancer of Natural Killer
Harmonized Tariff Schedule of the United States (2006) (Rev
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Ibudilast for the Treatment of Drug Addiction and Other Neurological Conditions
Drug Screening in a Zebrafish Model of Duchenne Muscular Dystrophy
Phosphodiesterases As Drug Targets (Handbook of Experimental
Operational Protocol
A Systematic Review of Drug Repurposing in Glioblastoma
Ibudilast, a Phosphodiesterase-4 Inhibitor, Ameliorates Acute Respiratory Distress Syndrome in Neonatal Mice by Alleviating Infl
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Supplementary Material
QVA149 / Indacaterol / Glycopyrronium Bromide
Pharmaceuticals Appendix
WO 2017/033032 Al 2 March 2017 (02.03.2017) P O P C T
An In-Vitro Model to Predict Cardiac Effects of Drugs
Mediated Activation of Microglial Cells
Comparing Biologicals and Small Molecule Drug Therapies for Chronic Respiratory Diseases
(12) United States Patent (10) Patent No.: US 9,333,195 B2 Fernandez Forner Et Al
Identifying Nootropic Drug Targets Via Large-Scale Cognitive GWAS and Transcriptomics